A review of prognostic and predictive biomarkers in breast cancer
E Tarighati, H Keivan, H Mahani - Clinical and experimental medicine, 2023 - Springer
Breast cancer (BC) is a common cancer all over the world that affects women. BC is one of
the leading causes of cancer mortality in women, which today has decreased with the …
the leading causes of cancer mortality in women, which today has decreased with the …
Classic and new markers in diagnostics and classification of breast cancer
R Beňačka, D Szabóová, Z Guľašová, Z Hertelyová… - Cancers, 2022 - mdpi.com
Simple Summary With ever-increasing incidence, breast cancer is considered a most
diagnosed type of cancer among women worldwide. Breast cancer arises through malignant …
diagnosed type of cancer among women worldwide. Breast cancer arises through malignant …
Transcription factors in cancer development and therapy
Cancer is a multi-step process and requires constitutive expression/activation of
transcription factors (TFs) for growth and survival. Many of the TFs reported so far are critical …
transcription factors (TFs) for growth and survival. Many of the TFs reported so far are critical …
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic …
Despite advances in breast cancer treatments and related 5-year survival outcomes,
metastatic breast cancer cures remain elusive. The current standard of care includes a …
metastatic breast cancer cures remain elusive. The current standard of care includes a …
Progesterone action in breast, uterine, and ovarian cancers
Progesterone and progesterone receptors (PRs) are essential for the development and
cyclical regulation of hormone-responsive tissues including the breast and reproductive …
cyclical regulation of hormone-responsive tissues including the breast and reproductive …
Progesterone signaling and uterine fibroid pathogenesis; molecular mechanisms and potential therapeutics
Uterine fibroids (UFs) are the most important benign neoplastic threat to women's health
worldwide, with a prevalence of up to 80% in premenopausal women, and can cause heavy …
worldwide, with a prevalence of up to 80% in premenopausal women, and can cause heavy …
Estrogen receptors-mediated apoptosis in hormone-dependent cancers
A Chimento, A De Luca, P Avena, F De Amicis… - International journal of …, 2022 - mdpi.com
It is known that estrogen stimulates growth and inhibits apoptosis through estrogen receptor
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …
Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling
Background Increased expression of the progesterone receptor membrane component 1
(PGRMC1) has been linked to multiple cancers, including breast cancer. Despite being a …
(PGRMC1) has been linked to multiple cancers, including breast cancer. Despite being a …
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer
The functional role of progesterone receptor (PR) and its impact on estrogen signaling in
breast cancer remain controversial. In primary ER+ (estrogen receptor–positive)/PR+ human …
breast cancer remain controversial. In primary ER+ (estrogen receptor–positive)/PR+ human …
[HTML][HTML] Unveiling the role of hormonal imbalance in breast cancer development: A comprehensive review
S Satpathi, SS Gaurkar, A Potdukhe, MB Wanjari - Cureus, 2023 - ncbi.nlm.nih.gov
Breast cancer is a complex and multifactorial disease with a significant global impact.
Hormonal imbalance has emerged as a crucial factor in breast cancer development …
Hormonal imbalance has emerged as a crucial factor in breast cancer development …